A 59-year-old man with a history of IgG kappa multiple myeloma presented to an outpatient facility for evaluation of left hip pain, which was found to be a pathologic fracture. He has had 2 autologous ...
Johnson & Johnson (NYSE: JNJ) today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA), seeking approval of IMAAVY® ...
In the era of Rhesus (Rh) immune globulin treatment, the non-D Rh antibodies are an increasingly significant cause of alloimmune hemolytic disease of the newborn (HDN). 1 While HDN due to anti-e has ...
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
Cold agglutinin disease is a rare autoimmune hemolytic anemia characterized by hemolysis that is caused by activation of the classic complement pathway. Sutimlimab, a humanized monoclonal antibody, ...
Hemolytic anemia occurs when red blood cells are destroyed faster than your bone marrow can make them. This can be caused by diseases, autoimmune disorders, or cancer. The treatment depends on the ...
An overview of the roles of plasmapheresis, IVIG, transfusions, and corticosteroids as treatment for patients with cold agglutinin disease. Neil Minkoff, MD: Let me push a little more on you, not ...
Autoimmune hemolytic anemia is a rare red blood cell disorder and an immune disorder. It happens when the body produces antibodies that destroy the red blood cells. Hemolytic anemia develops when ...
Is This Intravascular Immune Hemolysis? The term "immune" implies that the hemolysis is antibody-related. Because the type and antibody screen and the DAT were negative, the hemolysis was probably not ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results